Gain Therapeutics, Inc. (GANX) Operating Margin % [USD] 2020 - 2023

Historical data

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Gain Therapeutics, Inc. annual/quarterly Operating Margin history and growth rate from 2020 to 2023.
  • Gain Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2022 was -7.74 K %, a 1.45% decline year-over-year.
  • Gain Therapeutics, Inc. annual Operating Margin for 2023 was -40.3 K %, a 218% decline from 2022.
  • Gain Therapeutics, Inc. annual Operating Margin for 2022 was -12.7 K %, a 51.4% decline from 2021.
  • Gain Therapeutics, Inc. annual Operating Margin for 2021 was -8.38 K %, a 30.4% increase from 2020.
Operating Margin, Annual (% [USD])
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -40.3 K -27.6 K -218% Jan 1, 2023 Dec 31, 2023
2022 -12.7 K -4.31 K -51.4% Jan 1, 2022 Dec 31, 2022
2021 -8.38 K +3.67 K +30.4% Jan 1, 2021 Dec 31, 2021
2020 -12 K Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.